Nutrient depletion-induced production of tri-acylated glycerophospholipids in Acinetobacter radioresistens

Scientific Reports
Yu LuoXialu Chen

Abstract

Bacteria inhabit a vast range of biological niches and have evolved diverse mechanisms to cope with environmental stressors. The genus Acinetobacter comprises a complex group of Gram-negative bacteria. Some of these bacteria such as A. baumannii are nosocomial pathogens. They are often resistant to multiple antibiotics and are associated with epidemic outbreaks. A. radioresistens is generally considered to be a commensal bacterium on human skin or an opportunistic pathogen. Interestingly, this species has exceptional resistance to a range of environmental challenges which contributes to its persistence in clinical environment and on human skin. We studied changes in its lipid composition induced by the onset of stationary phase. This strain produced triglycerides (TG) as well as four common phospholipids: phosphatidylethanolamine (PE), phosphatidylglycerol (PG), cardiolipin (CL) and lysocardiolipin (LCL). It also produced small amounts of acyl-phosphatidylglycerol (APG). As the bacterial growth entered the stationary phase, the lipidome switched from one dominated by PE and PG to another dominated by CL and LCL. Surprisingly, bacteria in the stationary phase produced N-acyl-phosphatidylethanolamine (NAPE) and another rare lipid...Continue Reading

References

Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Sep 1, 1995·Applied and Environmental Microbiology·S Navon-VeneziaE Rosenberg
Aug 12, 1998·The Journal of Hospital Infection·A JawadP M Hawkey
Dec 19, 2001·Emerging Infectious Diseases·P ViscaN Petrosillo
Dec 6, 2002·Applied Microbiology and Biotechnology·H M Alvarez, A Steinbüchel
Jul 16, 2005·Journal of the American Society for Mass Spectrometry·Andrew M McAnoyRobert C Murphy
Mar 4, 2006·Microbiology·Claudia S LópezCarmen Sánchez-Rivas
Jan 16, 2008·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Feb 12, 2008·Nature Reviews. Microbiology·Yong-Mei Zhang, Charles O Rock
Sep 2, 2008·Folia Microbiologica·G Seydlová, J Svobodová
Apr 18, 2009·Biochimica Et Biophysica Acta·Eugenia Mileykovskaya, William Dowhan
Mar 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·Lars D Renner, Douglas B Weibel
Jun 10, 2011·Mass Spectrometry Reviews·Robert C Murphy, Paul H Axelsen
Oct 19, 2011·IUBMB Life·Paolo ViscaKevin J Towner
Jan 31, 2012·Plant Science : an International Journal of Experimental Plant Biology·Denis CoulonJean-Jacques Bessoule
Sep 19, 2012·Proceedings of the National Academy of Sciences of the United States of America·Brandon K TanZiqiang Guan
Jun 27, 2014·Journal of Proteome Research·Satoshi TanakaKoichi Tanaka
Mar 17, 2015·Journal of Cell Science·Harvey T McMahon, Emmanuel Boucrot
Apr 12, 2015·FEMS Microbiology Reviews·Christian Sohlenkamp, Otto Geiger
Oct 28, 2015·Journal of Mass Spectrometry : JMS·Denis Coulon, Corinne Buré
Aug 11, 2016·Journal of the American Society for Mass Spectrometry·Metin AtilaYu Luo
May 17, 2017·Extremophiles : Life Under Extreme Conditions·Melvin F SiliakusServé W M Kengen
May 23, 2017·Nature Reviews. Microbiology·Robert A FisherSophie Helaine
Jun 9, 2017·Scientific Reports·Patrizia LopalcoAngela Corcelli

❮ Previous
Next ❯

Datasets Mentioned

BETA
KX263725

Software Mentioned

SCIEX Analyst
PAGPE
GelAnalyzer
PerkinElmer ChemDraw prime
BLASTP

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.